Evolent Health Inc (NYSE: EVH) stock closed at $13.36 on 11/8/24 after a major decline of -45.6%. Moreover, this decline was accompanied by exceptionally high trading volume at 1032% of normal. The stock has declined -42.8% during the last week and has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
EVH’s future returns on capital are forecasted to exceed the cost of capital. Accordingly, the company is expected to continue to be an important Value Builder.
Evolent Health has a current Value Trend Rating of C (High Neutral). This rating combines contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Evolent Health has a good Appreciation Score of 83 but a slightly negative Power Rating of 37, with the High Neutral Value Trend Rating the result.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment